Compare OCS & CBZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCS | CBZ |
|---|---|---|
| Founded | 2003 | 1987 |
| Country | Switzerland | United States |
| Employees | 60 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | N/A | 1996 |
| Metric | OCS | CBZ |
|---|---|---|
| Price | $11.76 | $33.49 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | ★ $42.00 | $41.33 |
| AVG Volume (30 Days) | ★ 938.4K | 556.8K |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 134.62 |
| EPS | N/A | ★ 1.83 |
| Revenue | N/A | ★ $922,003,000.00 |
| Revenue This Year | $466.06 | $3.92 |
| Revenue Next Year | $479.73 | $4.12 |
| P/E Ratio | ★ N/A | $17.62 |
| Revenue Growth | N/A | ★ 7.79 |
| 52 Week Low | $11.70 | $24.29 |
| 52 Week High | $34.48 | $77.91 |
| Indicator | OCS | CBZ |
|---|---|---|
| Relative Strength Index (RSI) | 21.61 | 58.29 |
| Support Level | N/A | $27.84 |
| Resistance Level | $21.00 | $36.42 |
| Average True Range (ATR) | 2.26 | 1.54 |
| MACD | -2.18 | 0.18 |
| Stochastic Oscillator | 2.10 | 78.21 |
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the maximum of its revenues from the Financial Services segment and geographically from the United States.